These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21395514)

  • 21. Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.
    Bowerman CJ; Byrne JD; Chu KS; Schorzman AN; Keeler AW; Sherwood CA; Perry JL; Luft JC; Darr DB; Deal AM; Napier ME; Zamboni WC; Sharpless NE; Perou CM; DeSimone JM
    Nano Lett; 2017 Jan; 17(1):242-248. PubMed ID: 27966988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic core-shell nanoparticles for drug delivery by nebulization.
    Verma NK; Crosbie-Staunton K; Satti A; Gallagher S; Ryan KB; Doody T; McAtamney C; MacLoughlin R; Galvin P; Burke CS; Volkov Y; Gun'ko YK
    J Nanobiotechnology; 2013 Jan; 11():1. PubMed ID: 23343139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
    Mehta AK; Yadav KS; Sawant KK
    Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redefining the importance of polylactide-co-glycolide acid (PLGA) in drug delivery.
    Chavan YR; Tambe SM; Jain DD; Khairnar SV; Amin PD
    Ann Pharm Fr; 2022 Sep; 80(5):603-616. PubMed ID: 34896382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
    Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
    Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
    Leelakanok N; Geary S; Salem A
    J Pharm Sci; 2018 Feb; 107(2):513-528. PubMed ID: 29045885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
    Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
    J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poly(lactic-co-glycolic) Acid/Solutol HS15-Based Nanoparticles for Docetaxel Delivery.
    Cho HJ; Park JH; Kim DD; Yoon IS
    J Nanosci Nanotechnol; 2016 Feb; 16(2):1433-6. PubMed ID: 27433600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
    Acharya S; Sahoo SK
    Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rapamycin-loaded poly (lactic-co-glycolic) acid nanoparticles for intraarterial local drug delivery: preparation, characterization, and in vitro/in vivo release].
    Miao LF; Yang J; Huang CL; Song CX; Zeng YJ; Chen LF; Zhu WL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):491-7. PubMed ID: 18795627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
    Patel BK; Parikh RH; Patel N
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular Targeting of Poly Lactic-Co-Glycolic Acid Nanoparticles by Surface Functionalization with Peptides.
    de Oliveira TD; Travassos LR; Arruda DC; Tada DB
    J Biomed Nanotechnol; 2021 Jul; 17(7):1320-1329. PubMed ID: 34446135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells.
    Huang F; You M; Chen T; Zhu G; Liang H; Tan W
    Chem Commun (Camb); 2014 Mar; 50(23):3103-5. PubMed ID: 24516863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.
    Ding D; Zhu Q
    Mater Sci Eng C Mater Biol Appl; 2018 Nov; 92():1041-1060. PubMed ID: 30184728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tuning the Size of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles Fabricated by Nanoprecipitation.
    Huang W; Zhang C
    Biotechnol J; 2018 Jan; 13(1):. PubMed ID: 28941234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.